Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 4
2014 2
2015 4
2016 4
2017 5
2018 7
2019 13
2020 8
2021 12
2022 13
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
Autore F, Visentin A, Deodato M, Vitale C, Galli E, Fresa A, Fazzi R, Sanna A, Olivieri J, Scortechini I, Del Principe MI, Sportoletti P, Schiattone L, Maschio N, Facchinelli D, Marchesi F, Coscia M, Tedeschi A, Trentin L, Innocenti I, Candoni A, Busca A, Pagano L, Laurenti L. Autore F, et al. Am J Hematol. 2024 May;99(5):982-984. doi: 10.1002/ajh.27247. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38343033 No abstract available.
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.
D'Arena G, Vitale C, Pietrantuono G, Villani O, Mansueto G, D'Auria F, Statuto T, D'Agostino S, Sabetta R, Tarasco A, Innocenti I, Autore F, Fresa A, Valvano L, Tomasso A, Cafaro L, Lamorte D, Laurenti L. D'Arena G, et al. Among authors: autore f. Cancers (Basel). 2024 Jan 22;16(2):469. doi: 10.3390/cancers16020469. Cancers (Basel). 2024. PMID: 38275909 Free PMC article.
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience.
Innocenti I, Fresa A, Tomasso A, Tarnani M, De Padua L, Benintende G, Pasquale R, Galli E, Morelli F, Giannarelli D, Autore F, Laurenti L. Innocenti I, et al. Among authors: autore f. Cancers (Basel). 2023 Nov 26;15(23):5592. doi: 10.3390/cancers15235592. Cancers (Basel). 2023. PMID: 38067296 Free PMC article.
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
Autore F, Bramanti S, Lessi F, Innocenti I, Galli E, Rocchi S, Ribolla R, Derudas D, Oliva S, Stefanoni P, Marcatti M, Schenone A, La Nasa G, Crippa C, Zamagni E, Riva M, Mazza R, Mannina D, Sica S, Bacigalupo A, Laurenti L. Autore F, et al. Haematologica. 2024 Mar 1;109(3):888-894. doi: 10.3324/haematol.2023.283719. Haematologica. 2024. PMID: 37646655 Free PMC article.
Role of microRNAs in Chronic Lymphocytic Leukemia.
Autore F, Ramassone A, Stirparo L, Pagotto S, Fresa A, Innocenti I, Visone R, Laurenti L. Autore F, et al. Int J Mol Sci. 2023 Aug 5;24(15):12471. doi: 10.3390/ijms241512471. Int J Mol Sci. 2023. PMID: 37569845 Free PMC article. Review.
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T-cells (CAR-T): A comprehensive review on incidence, risk factors and current management.
Galli E, Fresa A, Bellesi S, Metafuni E, Maiolo E, Pansini I, Frioni F, Autore F, Limongiello MA, Innocenti I, Giammarco S, Chiusolo P, Zini G, Sorà F. Galli E, et al. Among authors: autore f. Eur J Haematol. 2024 Feb;112(2):184-196. doi: 10.1111/ejh.14052. Epub 2023 Jul 25. Eur J Haematol. 2024. PMID: 37491951 Review.
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
Autore F, Innocenti I, Reda G, Visentin A, Vitale C, Piciocchi A, Fresa A, Leone MMA, Farina L, Quaresmini G, Baratè C, Giordano A, Ferrari A, Angeletti I, De Paolis MR, Malerba L, Chiurazzi F, Loseto G, Catania G, Sportoletti P, Scortechini I, Moia R, Gentile M, Rigolin GM, Mattiello V, Gattei V, Coscia M, Trentin L, Foà R, Cuneo A, Laurenti L. Autore F, et al. Hematol Oncol. 2023 Dec;41(5):877-883. doi: 10.1002/hon.3199. Epub 2023 Jul 1. Hematol Oncol. 2023. PMID: 37392141
Measurable residual disease in chronic lymphocytic leukemia.
Benintende G, Pozzo F, Innocenti I, Autore F, Fresa A, D'Arena G, Gattei V, Lurenti L. Benintende G, et al. Among authors: autore f. Front Oncol. 2023 Feb 14;13:1112616. doi: 10.3389/fonc.2023.1112616. eCollection 2023. Front Oncol. 2023. PMID: 36865804 Free PMC article. Review.
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience.
Autore F, Chiusolo P, Sora' F, Laurenti L, Pagano L, Bacigalupo A, De Stefano V, Sica S. Autore F, et al. Mediterr J Hematol Infect Dis. 2023 Jan 1;15(1):e2023009. doi: 10.4084/MJHID.2023.009. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 36660356 Free PMC article. No abstract available.
77 results